Overactive Bladder - Results from #240

Risk Factors for De Novo Overactive Bladder After Midurethral Sling. June 18, 2023

Efficacy of Intravesical Botulinum Toxin A Injection in the Treatment of Refractory Overactive Bladder in Children. June 11, 2023

The translational implications of the science behind the overactive bladder and the role of OnabotulinumtoxinA. June 11, 2023

Digital health information on surgical treatment options for overactive bladder is underrepresented. June 6, 2023

One treatment with onabotulinumtoxinA relieves symptoms of overactive bladder in patients refractory to one or more oral medications. June 2, 2023

Vibegron 50 mg Once Daily Improves OABSS, OAB-q SF Score in OAB Patients ≥80 Years Old in Real-World Clinical Settings and Switching from Other OAB Drugs May Reduce Residual Urine Volume. May 31, 2023

Adherence to Overactive Bladder Syndrome Treatments Recent Developments and Future Perspectives. May 31, 2023

Assessment of Codispensing Patterns of Mirabegron and Prespecified CYP2D6 Substrates in Patients with Overactive Bladder. May 28, 2023

The Investigation of Percutaneous Tibial Nerve Stimulation (PTNS) as a Minimally Invasive, Non-Surgical, Non-Hormonal Treatment for Overactive Bladder Symptoms. May 28, 2023

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements. May 28, 2023

Retrospective Observational Study of Treatment Patterns and Efficacy of onabotulinumtoxinA Therapy in Patients with Refractory Overactive Bladder in Clinical Practice. May 28, 2023

Inequities in Filled Overactive Bladder Medication Prescriptions in the US. May 28, 2023

Analysis of Urinary Retention Caused by Selective β 3-adrenoceptor Agonists Using the Japanese Adverse Drug Event Report Database (JADER). May 21, 2023

Telemedicine in Overactive Bladder Syndrome. May 21, 2023

Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults. May 14, 2023

Defining bladder outlet obstruction and detrusor underactivity in females with overactive bladder: Are we forgetting about the free uroflowmetry? May 14, 2023

Update on Overactive Bladder Therapeutic Options. May 14, 2023

Identifying Patient-Centered Research Priorities in Overactive Bladder by Crowdsourcing and Targeted Recruitment. May 7, 2023

Mirabegron versus vibegron in previously untreated female patients with overactive bladder: A randomized, single-clinic, open-label trial. May 7, 2023

Differences between brain responses to peroneal electrical transcutaneous neuromodulation and transcutaneous tibial nerve stimulation, two treatments for overactive bladder. May 7, 2023

Page 13 of 122